Acquiring Company
AbbVie Inc.
Acquired Company
Apogee Therapeutics
Description
AbbVie has announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share in cash, valuing the company at approximately $10.9 billion. This acquisition aims to enhance AbbVie's immunology portfolio and accelerate its clinical capabilities in respiratory diseases. The transaction is expected to close in the third quarter of 2026, pending regulatory and shareholder approvals.
Quick answer
AbbVie Inc. is acquiring Apogee Therapeutics for $10.9 billion, announced June 22, 2026. AbbVie Inc. is based in North Chicago, Illinois, United States.
- How much did AbbVie Inc. pay for Apogee Therapeutics?
- The reported deal value is $10.9 billion.
- What does AbbVie Inc. do?
- Venture capital subsidiary of Abbvie
- Where are AbbVie Inc. and Apogee Therapeutics based?
- AbbVie Inc. is based in North Chicago, Illinois, United States. Apogee Therapeutics is based in San Francisco, California, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Tarsus acquires iRenix Medical for IRX-101 development (July 8, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Gilead Sciences to acquire MacroGenics for $1.7B, $1.7B (May 19, 2026)
- Vertex to acquire Crinetics Pharmaceuticals for $10B, $10B (July 6, 2026)
- Bora Pharmaceuticals acquires MacroGenics' operations (July 2, 2026)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Apogee Therapeutics?
Apogee Therapeutics was acquired by AbbVie Inc., based in North Chicago. The deal was reported on June 22, 2026. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire Apogee Therapeutics?
AbbVie Inc.'s acquisition of Apogee Therapeutics was reported on June 22, 2026. AbbVie has announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share in cash, valuing the company at approximately $10.9 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Apogee Therapeutics do?
Apogee Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative biologic therapies for inflammatory and immunology diseases. It is privately held, operating in research, and is based in San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.